Pharma Grade Xanthan Gum BP/EP from United States
Pharma-grade xanthan gum complying with British and European Pharmacopoeia standards, supplied in sterile primary powder form for use as a suspending agent in oral suspensions and syrups. This natural polysaccharide derivative falls under tariff item 3913.90.00 as a modified natural polymer in primary form, not elsewhere specified.
Duty Rate — United States → Canada
0%
Import Tips
• Maintain documentation proving pharmacopoeia compliance (BP/EP certificates) for CBSA and Health Canada review
• Ensure the product is in primary form and not formulated into a pharmaceutical preparation, which would be classified in Chapter 30
• Verify whether the sterile presentation affects classification, as sterilization alone does not remove it from Chapter 39